DK0700930T3 - Tumoraffinitetspeptid og radioaktivt diagnosticeringsmiddel og radioaktivt behandlingsmiddel indeholdende peptidet - Google Patents

Tumoraffinitetspeptid og radioaktivt diagnosticeringsmiddel og radioaktivt behandlingsmiddel indeholdende peptidet

Info

Publication number: DK0700930T3
Authority: DK; Denmark
Prior art keywords: amino acid; peptide; radioactive; acid sequence; acid residues
Prior art date: 1994-06-07

Application number

DK95108681T

Other languages

English (en)

Inventor

Ikuya Seki

Yoshitoshi Itaya

Yoshifumi Shirakami

Komei Washino

Original Assignee

Nihon Mediphysics Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-06-07

Filing date

1995-06-06

Publication date

1999-09-13

1995-06-06 Application filed by Nihon Mediphysics Co Ltd filed Critical Nihon Mediphysics Co Ltd

1999-09-13 Application granted granted Critical

1999-09-13 Publication of DK0700930T3 publication Critical patent/DK0700930T3/da

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1018—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against material from animals or humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Optics & Photonics (AREA)
Physics & Mathematics (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Oncology (AREA)
Cell Biology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK95108681T 1994-06-07 1995-06-06 Tumoraffinitetspeptid og radioaktivt diagnosticeringsmiddel og radioaktivt behandlingsmiddel indeholdende peptidet DK0700930T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP14865594		1994-06-07

Publications (1)

Publication Number	Publication Date
DK0700930T3 true DK0700930T3 (da)	1999-09-13

Family

ID=15457667

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK95108681T DK0700930T3 (da)	1994-06-07	1995-06-06	Tumoraffinitetspeptid og radioaktivt diagnosticeringsmiddel og radioaktivt behandlingsmiddel indeholdende peptidet

Country Status (11)

Country	Link
US (1)	US5827498A (da)
EP (1)	EP0700930B1 (da)
KR (1)	KR960000250A (da)
AT (1)	ATE175977T1 (da)
AU (1)	AU684348B2 (da)
CA (1)	CA2151099A1 (da)
DE (1)	DE69507408T2 (da)
DK (1)	DK0700930T3 (da)
ES (1)	ES2138111T3 (da)
MC (1)	MC2397A1 (da)
TW (1)	TW394777B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2165228A1 (en) *	1994-12-27	1996-06-28	Yoshitoshi Itaya	Metal chelate forming peptides and use thereof
EP2654769B1 (en)	2010-12-14	2020-04-15	Recepta Biopharma S.A.	Antitumor peptide derived from a complementarity determining region of a humanized monoclonal antibody to napi2b transporter
WO2013182650A1 (en)	2012-06-06	2013-12-12	INSERM (Institut National de la Santé et de la Recherche Médicale)	Method and pharmaceutical composition for use in the treatment of cancer
US11419951B2 (en) *	2017-08-19	2022-08-23	Ohio State Innovation Foundation	Peptide-based cancer imaging agents
CN107550864B (zh) *	2017-08-23	2020-12-18	科笛生物医药(上海)有限公司	Eppt多肽-聚乙二醇-磷脂复合膜材料、其制备方法及主动靶向脂质体递药系统和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5322678A (en) *	1988-02-17	1994-06-21	Neorx Corporation	Alteration of pharmacokinetics of proteins by charge modification
EP0442926A1 (en) *	1988-11-10	1991-08-28	Imperial Cancer Research Technology Limited	Polypeptides
US4986979A (en) *	1989-03-14	1991-01-22	Neorx Corporation	Imaging tissue sites of inflammation
ATE188387T1 (de) *	1991-02-08	2000-01-15	Diatide Inc	Technetium-99m markierte polypeptide zur bildformung
GB9108652D0 (en) *	1991-04-23	1991-06-12	Antisoma Ltd	Immunoreactive compounds

1995
- 1995-06-05 AU AU20499/95A patent/AU684348B2/en not_active Ceased
- 1995-06-05 US US08/463,230 patent/US5827498A/en not_active Expired - Fee Related
- 1995-06-06 CA CA002151099A patent/CA2151099A1/en not_active Abandoned
- 1995-06-06 ES ES95108681T patent/ES2138111T3/es not_active Expired - Lifetime
- 1995-06-06 AT AT9595108681T patent/ATE175977T1/de active
- 1995-06-06 EP EP95108681A patent/EP0700930B1/en not_active Expired - Lifetime
- 1995-06-06 DK DK95108681T patent/DK0700930T3/da active
- 1995-06-06 DE DE69507408T patent/DE69507408T2/de not_active Expired - Fee Related
- 1995-06-07 KR KR1019950014923A patent/KR960000250A/ko not_active Withdrawn
- 1995-11-16 TW TW084112123A patent/TW394777B/zh active
- 1995-11-28 MC MC2323A patent/MC2397A1/fr unknown

Also Published As

Publication number	Publication date
KR960000250A (ko)	1996-01-25
MC2397A1 (fr)	1996-07-26
CA2151099A1 (en)	1995-12-08
ES2138111T3 (es)	2000-01-01
EP0700930B1 (en)	1999-11-03
TW394777B (en)	2000-06-21
ATE175977T1 (de)	1999-02-15
DE69507408D1 (de)	1999-03-04
AU2049995A (en)	1995-12-14
AU684348B2 (en)	1997-12-11
DE69507408T2 (de)	2000-05-18
US5827498A (en)	1998-10-27
EP0700930A1 (en)	1996-03-13

Similar Documents

Publication	Publication Date	Title
MX9709913A (es)	1998-08-30	Metaloconstrucciones determinadas estructuralmente y aplicaciones.
MX9707430A (es)	1997-12-31	Complejos radiofarmaceuticos ternarios.
ATE146477T1 (de)	1997-01-15	Antimitotische derivate von binären catharanthus roseus
CA1262862C (en)	1989-11-14	Tetrapyrrole therapeutic agents
NO934837D0 (no)	1993-12-27	Porfycenforbindelser for fotodynamisk terapi
DK197386D0 (da)	1986-04-30	Terapeutiske praeparater til brug ved fotodiagnose og fototerapi
ES2146256T3 (es)	2000-08-01	Agentes de contraste que contienen perfluoro-1h,1h-neopentilo y metodo para usar el mismo.
GB9308957D0 (en)	1993-06-16	Novel produgs
DE69419919D1 (de)	1999-09-09	Technetium-99m markierte peptide zur bilderzeugung der entzuendung
IT1299175B1 (it)	2000-02-29	Composizione contenente radioisotopi immobilizzati su particelle solide, utile in particolare per la brachiterapia clinica in patologie
FR2707300B1 (fr)	1995-09-22	Composition de savon solide, transparente, à base de sels d'acides gras contenant de l'isoprèneglycol.
AU2049995A (en)	1995-12-14	Tumor affinity peptide, and radioactive diagnostic agent and adioactive therapeutic agent containing the peptide
ZA971537B (en)	1997-10-30	Pharmaceutical agents that contain perfluoroalkyl-containing metal complexes and their use in tumor therapy and interventional radiology.
BR9207126A (pt)	1995-08-29	Imunorreagente radioativo de marcação,composição formadora de imagem,composição terapêutica,processo para a formação de imagem diagnóstica em um sítio em um paciente e para tratar sítios de doença em um paciente,e,composição de matéria
ES2096040T3 (es)	1997-03-01	Nuevo reactivo para la representacion grafica de los tumores y su terapia.
GR1002903B (el)	1998-05-12	Πεπτιδιο συγγενες με ογκο και ραδιενεργος διαγνωστικος παραγοντας και ραδιενεργος θεραπευτικος παραγοντας που περιεχει το πεπτιδιο.
DK638088A (da)	1989-05-17	Substituerede dicarboxylsyre-bis(3,5-dicarbamoyl-2,4,6-trijodanilider), fremgangsmaade til fremstilling deraf samt roentgenkontrastmidler indeholdende disse
DK0759785T3 (da)	2002-02-18	Liposomsuspensioner som blodkontrastmidler
EP0659764B1 (en)	2000-03-01	Peptides modified by the phosphine group for marking with 99mTC and 186-188Re or paramagnetic agents
BR9407347A (pt)	1996-10-08	Complexos de sulfato de tris (isonitrila) cobre I método para sua preparação método para a preparação de um complexo de coordenação de uma isonitrila ligante e radionuclídeo kit estéril e não pitogênico para a sua preparação
KR940014436A (ko)	1994-07-18	2-아미노-6,7-디히드록시-4-티아헵탄산 유도체, 그의 제조방법 및 용도
DE3063755D1 (en)	1983-07-21	Technetium-99m labeled acetanilidoiminodiacetates for liver function diagnosis and process for their preparation
US5734011A (en)	1998-03-31	Ligand precursors for incorporation into peptides
ES2043784T3 (es)	1994-01-01	Procedimiento de preparacion de compuestos guanidinicos.
ATE89567T1 (de)	1993-06-15	Konjugate von vinblastin und seine derivate, verfahren zur herstellung derselben und diese konjugate enthaltende pharmazeutische zusammensetzungen.